<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">
<PubmedArticleSet>
  <PubmedArticle>
    <MedlineCitation Status="MEDLINE" Owner="NLM">
      <PMID Version="1">30304866</PMID>
      <DateCompleted>
        <Year>2019</Year>
        <Month>01</Month>
        <Day>14</Day>
      </DateCompleted>
      <DateRevised>
        <Year>2019</Year>
        <Month>01</Month>
        <Day>14</Day>
      </DateRevised>
      <Article PubModel="Electronic">
        <Journal>
          <ISSN IssnType="Electronic">1422-0067</ISSN>
          <JournalIssue CitedMedium="Internet">
            <Volume>19</Volume>
            <Issue>10</Issue>
            <PubDate>
              <Year>2018</Year>
              <Month>Oct</Month>
              <Day>09</Day>
            </PubDate>
          </JournalIssue>
          <Title>International journal of molecular sciences</Title>
          <ISOAbbreviation>Int J Mol Sci</ISOAbbreviation>
        </Journal>
        <ArticleTitle>Nutritional Modulation of AMPK-Impact upon Metabolic-Inflammation.</ArticleTitle>
        <ELocationID EIdType="pii" ValidYN="Y">3092</ELocationID>
        <ELocationID EIdType="doi" ValidYN="Y">10.3390/ijms19103092</ELocationID>
        <Abstract>
          <AbstractText>Nutritional status provides metabolic substrates to activate AMP-Activated Protein Kinase (AMPK), the energy sensor that regulates metabolism. Recent evidence has demonstrated that AMPK has wider functions with respect to regulating immune cell metabolism and function. One such example is the regulatory role that AMPK has on NLRP3-inlflammasome and IL-1β biology. This in turn can result in subsequent negative downstream effects on glucose, lipid and insulin metabolism. Nutrient stress in the form of obesity can impact AMPK and whole-body metabolism, leading to complications such as type 2 diabetes and cancer risk. There is a lack of data regarding the nature and extent that nutrient status has on AMPK and metabolic-inflammation. However, emerging work elucidates to a direct role of individual nutrients on AMPK and metabolic-inflammation, as a possible means of modulating AMPK activity. The posit being to use such nutritional agents to re-configure metabolic-inflammation towards more oxidative phosphorylation and promote the resolution of inflammation. The complex paradigm will be discussed within the context of if/how dietary components, nutrients including fatty acids and non-nutrient food components, such as resveratrol, berberine, curcumin and the flavonoid genistein, modulate AMPK dependent processes relating to inflammation and metabolism.</AbstractText>
        </Abstract>
        <AuthorList CompleteYN="Y">
          <Author ValidYN="Y">
            <LastName>Lyons</LastName>
            <ForeName>Claire L</ForeName>
            <Initials>CL</Initials>
            <AffiliationInfo>
              <Affiliation>Unit of Molecular Metabolism, Lund University Diabetes Center, Clinical Research Center, Lund University, 205 02 Malmö, Sweden. claire.lyons@med.lu.se.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Nutrigenomics Research Group, UCD Institute of Food and Health, UCD Conway Institute of Biomolecular and Biomedical Research, University College Dublin, Belfield, 4 Dublin, Ireland. claire.lyons@med.lu.se.</Affiliation>
            </AffiliationInfo>
          </Author>
          <Author ValidYN="Y">
            <LastName>Roche</LastName>
            <ForeName>Helen M</ForeName>
            <Initials>HM</Initials>
            <AffiliationInfo>
              <Affiliation>Nutrigenomics Research Group, UCD Institute of Food and Health, UCD Conway Institute of Biomolecular and Biomedical Research, University College Dublin, Belfield, 4 Dublin, Ireland. helen.roche@ucd.ie.</Affiliation>
            </AffiliationInfo>
            <AffiliationInfo>
              <Affiliation>Institute of Global Food Security, Queen's University Belfast BT7 1NN, Northern Ireland, UK. helen.roche@ucd.ie.</Affiliation>
            </AffiliationInfo>
          </Author>
        </AuthorList>
        <Language>eng</Language>
        <PublicationTypeList>
          <PublicationType UI="D016428">Journal Article</PublicationType>
          <PublicationType UI="D016454">Review</PublicationType>
        </PublicationTypeList>
        <ArticleDate DateType="Electronic">
          <Year>2018</Year>
          <Month>10</Month>
          <Day>09</Day>
        </ArticleDate>
      </Article>
      <MedlineJournalInfo>
        <MedlineTA>Int J Mol Sci</MedlineTA>
        <NlmUniqueID>101092791</NlmUniqueID>
        <ISSNLinking>1422-0067</ISSNLinking>
      </MedlineJournalInfo>
      <ChemicalList>
        <Chemical>
          <RegistryNumber>0</RegistryNumber>
          <NameOfSubstance UI="D015415">Biomarkers</NameOfSubstance>
        </Chemical>
        <Chemical>
          <RegistryNumber>EC 2.7.11.31</RegistryNumber>
          <NameOfSubstance UI="D055372">AMP-Activated Protein Kinases</NameOfSubstance>
        </Chemical>
      </ChemicalList>
      <CitationSubset>IM</CitationSubset>
      <MeshHeadingList>
        <MeshHeading>
          <DescriptorName UI="D055372" MajorTopicYN="N">AMP-Activated Protein Kinases</DescriptorName>
          <QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D015415" MajorTopicYN="N">Biomarkers</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D004734" MajorTopicYN="Y">Energy Metabolism</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D004789" MajorTopicYN="N">Enzyme Activation</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007249" MajorTopicYN="N">Inflammation</DescriptorName>
          <QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName>
          <QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D007333" MajorTopicYN="N">Insulin Resistance</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D009369" MajorTopicYN="N">Neoplasms</DescriptorName>
          <QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName>
          <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D009747" MajorTopicYN="Y">Nutritional Physiological Phenomena</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D009752" MajorTopicYN="N">Nutritional Status</DescriptorName>
        </MeshHeading>
        <MeshHeading>
          <DescriptorName UI="D015398" MajorTopicYN="N">Signal Transduction</DescriptorName>
        </MeshHeading>
      </MeshHeadingList>
      <KeywordList Owner="NOTNLM">
        <Keyword MajorTopicYN="N">AMPK</Keyword>
        <Keyword MajorTopicYN="N">IL-1β</Keyword>
        <Keyword MajorTopicYN="N">NLRP3</Keyword>
        <Keyword MajorTopicYN="N">dietary fatty acids</Keyword>
        <Keyword MajorTopicYN="N">metabolic-inflammation</Keyword>
        <Keyword MajorTopicYN="N">nutrigenomics</Keyword>
        <Keyword MajorTopicYN="N">nutrition</Keyword>
      </KeywordList>
      <CoiStatement>The authors declare no conflict of interest.</CoiStatement>
    </MedlineCitation>
    <PubmedData>
      <History>
        <PubMedPubDate PubStatus="received">
          <Year>2018</Year>
          <Month>9</Month>
          <Day>7</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="revised">
          <Year>2018</Year>
          <Month>10</Month>
          <Day>3</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="accepted">
          <Year>2018</Year>
          <Month>10</Month>
          <Day>6</Day>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="entrez">
          <Year>2018</Year>
          <Month>10</Month>
          <Day>12</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="pubmed">
          <Year>2018</Year>
          <Month>10</Month>
          <Day>12</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
        <PubMedPubDate PubStatus="medline">
          <Year>2019</Year>
          <Month>1</Month>
          <Day>15</Day>
          <Hour>6</Hour>
          <Minute>0</Minute>
        </PubMedPubDate>
      </History>
      <PublicationStatus>epublish</PublicationStatus>
      <ArticleIdList>
        <ArticleId IdType="pubmed">30304866</ArticleId>
        <ArticleId IdType="pmc">PMC6213547</ArticleId>
        <ArticleId IdType="doi">10.3390/ijms19103092</ArticleId>
        <ArticleId IdType="pii">ijms19103092</ArticleId>
      </ArticleIdList>
      <ReferenceList>
        <Reference>
          <Citation>Hardie D.G. The AMP-activated protein kinase pathway—New players upstream and downstream. J. Cell Sci. 2004;117:5479–5487. doi: 10.1242/jcs.01540.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1242/jcs.01540</ArticleId>
            <ArticleId IdType="pubmed">15509864</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Finucane O.M., Lyons C.L., Murphy A.M., Reynolds C.M., Klinger R., Healy N.P., Cooke A.A., Coll R.C., McAllan L., Nilaweera K.N., et al.  Monounsaturated fatty acid-enriched high-fat diets impede adipose NLRP3 inflammasome-mediated IL-1? Secretion and insulin resistance despite obesity. Diabetes. 2015;64:2116–2128. doi: 10.2337/db14-1098.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2337/db14-1098</ArticleId>
            <ArticleId IdType="pubmed">25626736</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Knowler W.C., Connor E.B., Fowler S.E., Hamman R.F., Lachin J.M., Walker E.A., Nathan D.M. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N. Engl. J. Med. 2002;346:393–403.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC1370926</ArticleId>
            <ArticleId IdType="pubmed">11832527</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Stein S.C., Woods A., Jones J.A., Davison M.D., Carling D. The regulation of AMP-activated protein kinase by phosphorylation. Biochem. J. 2000;345:437–443. doi: 10.1042/bj3450437.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1042/bj3450437</ArticleId>
            <ArticleId IdType="pmc">PMC1220775</ArticleId>
            <ArticleId IdType="pubmed">10642499</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hawley S.A., Davison M., Woods A., Davies S.P., Beri R.K., Carling D., Hardie D.G. Characterization of the AMP-activated protein kinase kinase from rat liver and identification of threonine 172 as the major site at which it phosphorylates AMP-activated protein kinase. J. Biol. Chem. 1996;271:27879–27887. doi: 10.1074/jbc.271.44.27879.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1074/jbc.271.44.27879</ArticleId>
            <ArticleId IdType="pubmed">8910387</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Xiao B., Sanders M.J., Underwood E., Heath R., Mayer F.V., Carmena D., Jing C., Walker P.A., Eccleston J.F., Haire L.F., et al.  Structure of mammalian AMPK and its regulation by ADP. Nature. 2011;472:230–233. doi: 10.1038/nature09932.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nature09932</ArticleId>
            <ArticleId IdType="pmc">PMC3078618</ArticleId>
            <ArticleId IdType="pubmed">21399626</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Oakhill J.S., Chen Z.P., Scott J.W., Steel R., Castelli L.A., Ling N., Macaulay S.L., Kemp B.E. β-Subunit myristoylation is the gatekeeper for initiating metabolic stress sensing by AMP-activated protein kinase (AMPK) Proc. Natl. Acad. Sci. USA. 2010;107:19237–19241. doi: 10.1073/pnas.1009705107.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1073/pnas.1009705107</ArticleId>
            <ArticleId IdType="pmc">PMC2984171</ArticleId>
            <ArticleId IdType="pubmed">20974912</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Valentine R.J., Coughlan K.A., Ruderman N.B., Saha A.K. Insulin inhibits AMPK activity and phosphorylates AMPK Ser485/491 through Akt in hepatocytes, myotubes and incubated rat skeletal muscle. Arch. Biochem. Biophys. 2014;562:62–69. doi: 10.1016/j.abb.2014.08.013.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.abb.2014.08.013</ArticleId>
            <ArticleId IdType="pmc">PMC4437572</ArticleId>
            <ArticleId IdType="pubmed">25172224</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mihaylova M.M., Shaw R.J. The AMPK signalling pathway coordinates cell growth, autophagy and metabolism. Nat. Cell Biol. 2011;13:1016–1023. doi: 10.1038/ncb2329.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/ncb2329</ArticleId>
            <ArticleId IdType="pmc">PMC3249400</ArticleId>
            <ArticleId IdType="pubmed">21892142</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hardie D.G., Ross F.A., Hawley S.A. AMPK: A nutrient and energy sensor that maintains energy homeostasis. Nat. Rev. Mol. Cell Biol. 2012;13:251–262. doi: 10.1038/nrm3311.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nrm3311</ArticleId>
            <ArticleId IdType="pmc">PMC5726489</ArticleId>
            <ArticleId IdType="pubmed">22436748</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Herzig S., Shaw R.J. AMPK: Guardian of metabolism and mitochondrial homeostasis. Nat. Rev. Mol. Cell Biol. 2017;19:121–135. doi: 10.1038/nrm.2017.95.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nrm.2017.95</ArticleId>
            <ArticleId IdType="pmc">PMC5780224</ArticleId>
            <ArticleId IdType="pubmed">28974774</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>O’Neill L.A.J., Hardie D.G. Metabolism of inflammation limited by AMPK and pseudo-starvation. Nature. 2013;493:346–355. doi: 10.1038/nature11862.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nature11862</ArticleId>
            <ArticleId IdType="pubmed">23325217</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>O’Neill H.M., Holloway G.P. AMPK regulation of fatty acid metabolism and mitochondrial biogenesis: Implications for obesity. Mol. Cell. Endocrinol. 2013;366:135–151. doi: 10.1016/j.mce.2012.06.019.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.mce.2012.06.019</ArticleId>
            <ArticleId IdType="pubmed">22750049</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhang C.S., Hawley S.A., Zong Y., Li M., Wang Z., Gray A., Ma T., Cui J., Feng J.W., Zhu M., et al.  Fructose-1,6-bisphosphate and aldolase mediate glucose sensing by AMPK. Nature. 2017;548:112–116. doi: 10.1038/nature23275.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nature23275</ArticleId>
            <ArticleId IdType="pmc">PMC5544942</ArticleId>
            <ArticleId IdType="pubmed">28723898</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Gauthier M.S., O’Brien E.L., Bigornia S., Mott M., Cacicedo J.M., Xu X.J., Gokce N., Apovian C., Ruderman N. Decreased AMP-activated protein kinase activity is associated with increased inflammation in visceral adipose tissue and with whole-body insulin resistance in morbidly obese humans. Biochem. Biophys. Res. Commun. 2011;404:382–387. doi: 10.1016/j.bbrc.2010.11.127.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.bbrc.2010.11.127</ArticleId>
            <ArticleId IdType="pmc">PMC3061625</ArticleId>
            <ArticleId IdType="pubmed">21130749</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Galic S., Fullerton M.D., Schertzer J.D., Sikkema S., Marcinko K., Walkley C.R., Izon D., Honeyman J., Chen Z.P., van Denderen B.J., et al.  Hematopoietic AMPK β1 reduces mouse adipose tissue macrophage inflammation and insulin resistance in obesity. J. Clin. Investig. 2011;121:4903–4915. doi: 10.1172/JCI58577.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1172/JCI58577</ArticleId>
            <ArticleId IdType="pmc">PMC3226000</ArticleId>
            <ArticleId IdType="pubmed">22080866</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tikoo K., Sharma E., Amara V.R., Pamulapati H., Dhawale V.S. Metformin improves metabolic memory in high fat diet (HFD)-induced renal dysfunction. J. Biol. Chem. 2016;291:21848–21856. doi: 10.1074/jbc.C116.732990.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1074/jbc.C116.732990</ArticleId>
            <ArticleId IdType="pmc">PMC5063970</ArticleId>
            <ArticleId IdType="pubmed">27551045</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yavari A., Stocker C.J., Ghaffari S., Wargent E.T., Steeples V., Czibik G., Pinter K., Bellahcene M., Woods A., Martínez de Morentin P.B., et al.  Chronic Activation of γ2 AMPK Induces Obesity and Reduces β Cell Function. Cell Metab. 2016;23:821–836. doi: 10.1016/j.cmet.2016.04.003.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.cmet.2016.04.003</ArticleId>
            <ArticleId IdType="pmc">PMC4873618</ArticleId>
            <ArticleId IdType="pubmed">27133129</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Arita Y., Kihara S., Ouchi N., Takahashi M., Maeda K., Miyagawa J., Hotta K., Shimomura I., Nakamura T., Miyaoka K., et al.  Paradoxical Decrease of an Adipose-Specific Protein, Adiponectin, in Obesity. Biochem. Biophys. Res. Commun. 1999;257:79–83. doi: 10.1006/bbrc.1999.0255.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1006/bbrc.1999.0255</ArticleId>
            <ArticleId IdType="pubmed">10092513</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kadowaki T., Yamauchi T., Kubota N., Hara K., Ueki K., Tobe K. Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome. J. Clin. Investig. 2006;116:1784–1792. doi: 10.1172/JCI29126.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1172/JCI29126</ArticleId>
            <ArticleId IdType="pmc">PMC1483172</ArticleId>
            <ArticleId IdType="pubmed">16823476</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Declèves A.-E., Mathew A.V., Cunard R., Sharma K. AMPK mediates the initiation of kidney disease induced by a high-fat diet. J. Am. Soc. Nephrol. 2011;22:1846–1855. doi: 10.1681/ASN.2011010026.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1681/ASN.2011010026</ArticleId>
            <ArticleId IdType="pmc">PMC3187184</ArticleId>
            <ArticleId IdType="pubmed">21921143</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yang Z., Kahn B.B., Shi H., Xue B.Z. Macrophage α1 AMP-activated protein kinase (α1 AMPK) antagonizes fatty acid-induced inflammation through SIRT1. J. Biol. Chem. 2010;285:19051–19059. doi: 10.1074/jbc.M110.123620.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1074/jbc.M110.123620</ArticleId>
            <ArticleId IdType="pmc">PMC2885183</ArticleId>
            <ArticleId IdType="pubmed">20421294</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mottillo E.P., Desjardins E.M., Crane J.D., Smith B.K., Green A.E., Ducommun S., Henriksen T.I., Rebalka I.A., Razi A., Sakamoto K., et al.  Lack of Adipocyte AMPK Exacerbates Insulin Resistance and Hepatic Steatosis through Brown and Beige Adipose Tissue Function. Cell Metab. 2016;24:118–129. doi: 10.1016/j.cmet.2016.06.006.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.cmet.2016.06.006</ArticleId>
            <ArticleId IdType="pmc">PMC5239668</ArticleId>
            <ArticleId IdType="pubmed">27411013</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Leclerc I., Woltersdorf W.W., da Silva Xavier G., Rowe R.L., Cross S.E., Korbutt G.S., Rajotte R.V., Smith R., Rutter G.A. Metformin, but not leptin, regulates AMP-activated protein kinase in pancreatic islets: Impact on glucose-stimulated insulin secretion. Am. J. Physiol. Endocrinol. Metab. 2004;286:E1023–E1031. doi: 10.1152/ajpendo.00532.2003.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1152/ajpendo.00532.2003</ArticleId>
            <ArticleId IdType="pubmed">14871885</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Da Silva Xavier G., Leclerc I., Varadi A., Tsuboi T., Moule S.K., Rutter G.A. Role of AMP-activated protein kinase in the regulation by glucose of islet β cell gene expression. Proc. Natl. Acad. Sci. USA. 2000;97:4023–4028. doi: 10.1073/pnas.97.8.4023.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1073/pnas.97.8.4023</ArticleId>
            <ArticleId IdType="pmc">PMC18135</ArticleId>
            <ArticleId IdType="pubmed">10760274</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mottillo E.P., Balasubramanian P., Lee Y.-H., Weng C., Kershaw E.E., Granneman J.G. Coupling of lipolysis and de novo lipogenesis in brown, beige, and white adipose tissues during chronic β3-adrenergic receptor activation. J. Lipid Res. 2014;55:2276–2286. doi: 10.1194/jlr.M050005.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1194/jlr.M050005</ArticleId>
            <ArticleId IdType="pmc">PMC4617130</ArticleId>
            <ArticleId IdType="pubmed">25193997</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kim S.J., Tang T., Abbott M., Viscarra J.A., Wang Y., Sul H.S. AMPK phosphorylates desnutrin/ATGL and HSL to regulate lipolysis and fatty acid oxidation within adipose tissue. Mol. Cell. Biol. 2016;36:1961–1976. doi: 10.1128/MCB.00244-16.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1128/MCB.00244-16</ArticleId>
            <ArticleId IdType="pmc">PMC4936063</ArticleId>
            <ArticleId IdType="pubmed">27185873</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Habinowski S.A., Witters L.A. The Effects of AICAR on Adipocyte Differentiation of 3T3-L1 Cells. Biochem. Biophys. Res. Commun. 2001;286:852–856. doi: 10.1006/bbrc.2001.5484.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1006/bbrc.2001.5484</ArticleId>
            <ArticleId IdType="pubmed">11527376</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ceddia R.B. The role of AMP-activated protein kinase in regulating white adipose tissue metabolism. Mol. Cell. Endocrinol. 2013;366:194–203. doi: 10.1016/j.mce.2012.06.014.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.mce.2012.06.014</ArticleId>
            <ArticleId IdType="pubmed">22750051</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Villena J.A., Viollet B., Andreelli F., Kahn A., Vaulont S., Sul H.S. Induced Adiposity and Adipocyte Hypertrophy in Mice Lacking the AMP-Activated Protein Kinase-alpha2 Subunit. Diabetes. 2004;53:2242–2249. doi: 10.2337/diabetes.53.9.2242.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2337/diabetes.53.9.2242</ArticleId>
            <ArticleId IdType="pubmed">15331533</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Zhang W., Zhang X., Wang H., Guo X., Li H., Wang Y., Xu X., Tan L., Mashek M.T., Zhang C., et al.  AMP-activated protein kinase α1 protects against diet-induced insulin resistance and obesity. Diabetes. 2012;61:3114–3125.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pmc">PMC3501873</ArticleId>
            <ArticleId IdType="pubmed">22829451</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jing Y., Wu F., Li D., Yang L., Li Q., Li R. Metformin improves obesity-associated inflammation by altering macrophages polarization. Mol. Cell. Endocrinol. 2018;461:256–264. doi: 10.1016/j.mce.2017.09.025.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.mce.2017.09.025</ArticleId>
            <ArticleId IdType="pubmed">28935544</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Li W., Saud S.M., Young M.R., Chen G., Hua B. Targeting AMPK for cancer prevention and treatment. Oncotarget. 2015;6:7365–7378. doi: 10.18632/oncotarget.3629.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.18632/oncotarget.3629</ArticleId>
            <ArticleId IdType="pmc">PMC4480686</ArticleId>
            <ArticleId IdType="pubmed">25812084</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Motoshima H., Goldstein B.J., Igata M., Araki E. AMPK and cell proliferation—AMPK as a therapeutic target for atherosclerosis and cancer. J. Physiol. 2006;574:63–71. doi: 10.1113/jphysiol.2006.108324.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1113/jphysiol.2006.108324</ArticleId>
            <ArticleId IdType="pmc">PMC1817805</ArticleId>
            <ArticleId IdType="pubmed">16613876</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hardie D.G. Molecular Pathways: Is AMPK a Friend or a Foe in Cancer? Clin. Cancer Res. 2015;21:3836–3840. doi: 10.1158/1078-0432.CCR-14-3300.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1158/1078-0432.CCR-14-3300</ArticleId>
            <ArticleId IdType="pmc">PMC4558946</ArticleId>
            <ArticleId IdType="pubmed">26152739</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Carretero J., Medina P.P., Blanco R., Smit L., Tang M., Roncador G., Maestre L., Conde E., Lopez-Rios F., Clevers H.C., et al.  Dysfunctional AMPK activity, signalling through mTOR and survival in response to energetic stress in LKB1-deficient lung cancer. Oncogene. 2007;26:1616–1625. doi: 10.1038/sj.onc.1209951.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/sj.onc.1209951</ArticleId>
            <ArticleId IdType="pubmed">16953221</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rothwell P.M., Fowkes F.G., Belch J.F., Ogawa H., Warlow C.P., Meade T.W. Effect of daily aspirin on long-term risk of death due to cancer: Analysis of individual patient data from randomised trials. Lancet. 2011;377:31–41. doi: 10.1016/S0140-6736(10)62110-1.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/S0140-6736(10)62110-1</ArticleId>
            <ArticleId IdType="pubmed">21144578</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Evans J.M.M., Donnelly L.A., Emslie-Smith A.M., Alessi D.R., Morris A.D. Metformin and reduced risk of cancer in diabetic patients. BMJ. 2005;330:1304–1305. doi: 10.1136/bmj.38415.708634.F7.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1136/bmj.38415.708634.F7</ArticleId>
            <ArticleId IdType="pmc">PMC558205</ArticleId>
            <ArticleId IdType="pubmed">15849206</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Liang J., Mills G.B. AMPK: A Contextual Oncogene or Tumor Suppressor? Cancer Res. 2013;73:2929–2935. doi: 10.1158/0008-5472.CAN-12-3876.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1158/0008-5472.CAN-12-3876</ArticleId>
            <ArticleId IdType="pmc">PMC3725287</ArticleId>
            <ArticleId IdType="pubmed">23644529</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yang Y. Metformin for cancer prevention. Front. Med. 2011;5:115–117. doi: 10.1007/s11684-011-0112-3.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s11684-011-0112-3</ArticleId>
            <ArticleId IdType="pubmed">21695613</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Vandanmagsar B., Youm Y.H., Ravussin A., Galgani J.E., Stadler K., Mynatt R.L., Ravussin E., Stephens J.M., Dixit V.D. The NLRP3 inflammasome instigates obesity-induced inflammation and insulin resistance. Nat. Med. 2011;17:179–188. doi: 10.1038/nm.2279.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nm.2279</ArticleId>
            <ArticleId IdType="pmc">PMC3076025</ArticleId>
            <ArticleId IdType="pubmed">21217695</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Stienstra R., Joosten L.A., Koenen T., van Tits B., van Diepen J.A., van den Berg S.A., Rensen P.C., Voshol P.J., Fantuzzi G., Hijmans A., et al.  The inflammasome-mediated caspase-1 activation controls adipocyte differentiation and insulin sensitivity. Cell Metab. 2010;12:593–605. doi: 10.1016/j.cmet.2010.11.011.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.cmet.2010.11.011</ArticleId>
            <ArticleId IdType="pmc">PMC3683568</ArticleId>
            <ArticleId IdType="pubmed">21109192</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pilon G., Dallaire P., Marette A. Inhibition of Inducible Nitric-oxide Synthase by Activators of AMP-activated Protein Kinase. J. Biol. Chem. 2004;279:20767. doi: 10.1074/jbc.M401390200.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1074/jbc.M401390200</ArticleId>
            <ArticleId IdType="pubmed">14985344</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wen H., Gris D., Lei Y., Jha S., Zhang L., Huang M.T., Brickey W.J., Ting J.P. Fatty acid-induced NLRP3-ASC inflammasome activation interferes with insulin signaling. Nat. Immunol. 2011;12:408–415. doi: 10.1038/ni.2022.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/ni.2022</ArticleId>
            <ArticleId IdType="pmc">PMC4090391</ArticleId>
            <ArticleId IdType="pubmed">21478880</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lee H.M., Kim J.J., Kim H.J., Shong M., Ku B.J., Jo E.K. Upregulated NLRP3 inflammasome activation in patients with type 2 diabetes. Diabetes. 2013;62:194–204. doi: 10.2337/db12-0420.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2337/db12-0420</ArticleId>
            <ArticleId IdType="pmc">PMC3526026</ArticleId>
            <ArticleId IdType="pubmed">23086037</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hawley S.A., Ross F.A., Chevtzoff C., Green K.A., Evans A., Fogarty S., Towler M.C., Brown L.J., Ogunbayo O.A., Evans A.M., et al.  Use of cells expressing γ subunit variants to identify diverse mechanisms of AMPK activation. Cell Metab. 2010;11:554–565. doi: 10.1016/j.cmet.2010.04.001.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.cmet.2010.04.001</ArticleId>
            <ArticleId IdType="pmc">PMC2935965</ArticleId>
            <ArticleId IdType="pubmed">20519126</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Iacobazzi V., Infantino V. Citrate—New functions for an old metabolite. Biol. Chem. 2014;395:387–399. doi: 10.1515/hsz-2013-0271.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1515/hsz-2013-0271</ArticleId>
            <ArticleId IdType="pubmed">24445237</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Wolf A.J., Reyes C.N., Liang W., Becker C., Shimada K., Wheeler M.L., Cho H.C., Popescu N.I., Coggeshall K.M., Arditi M., et al.  Hexokinase Is an Innate Immune Receptor for the Detection of Bacterial Peptidoglycan. Cell. 2016;166:624–636. doi: 10.1016/j.cell.2016.05.076.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.cell.2016.05.076</ArticleId>
            <ArticleId IdType="pmc">PMC5534359</ArticleId>
            <ArticleId IdType="pubmed">27374331</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Mills E.L., Kelly B., Logan A., Costa A.S.H., Varma M., Bryant C.E., Tourlomousis P., Däbritz J.H.M., Gottlieb E., Latorre I., et al.  Succinate Dehydrogenase Supports Metabolic Repurposing of Mitochondria to Drive Inflammatory Macrophages. Cell. 2016;167:457–470. doi: 10.1016/j.cell.2016.08.064.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.cell.2016.08.064</ArticleId>
            <ArticleId IdType="pmc">PMC5863951</ArticleId>
            <ArticleId IdType="pubmed">27667687</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Tannahill G.M., Curtis A.M., Adamik J., Palsson-McDermott E.M., McGettrick A.F., Goel G., Frezza C., Bernard N.J., Kelly B., Foley N.H., et al.  Succinate is an inflammatory signal that induces IL-1β through HIF-1α. Nature. 2013;496:238–242. doi: 10.1038/nature11986.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/nature11986</ArticleId>
            <ArticleId IdType="pmc">PMC4031686</ArticleId>
            <ArticleId IdType="pubmed">23535595</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>McArdle M.A., Finucane O.M., Connaughton R.M., McMorrow A.M., Roche H.M. Mechanisms of obesity-induced inflammation and insulin resistance: Insights into the emerging role of nutritional strategies. Front. Endocrinol. 2013;4:52. doi: 10.3389/fendo.2013.00052.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3389/fendo.2013.00052</ArticleId>
            <ArticleId IdType="pmc">PMC3650620</ArticleId>
            <ArticleId IdType="pubmed">23675368</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cooke A.A., Connaughton R.M., Lyons C.L., McMorrow A.M., Roche H.M. Fatty acids and chronic low grade inflammation associated with obesity and the metabolic syndrome. Eur. J. Pharmacol. 2016;785:207–214. doi: 10.1016/j.ejphar.2016.04.021.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.ejphar.2016.04.021</ArticleId>
            <ArticleId IdType="pubmed">27083551</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Murphy A.M., Lyons C.L., Finucane O.M., Roche H.M. Interactions between differential fatty acids and inflammatory stressors-impact on metabolic health. Prostaglandins Leukot. Essent. Fat. Acids. 2015;92:49–55. doi: 10.1016/j.plefa.2014.05.003.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.plefa.2014.05.003</ArticleId>
            <ArticleId IdType="pubmed">24947613</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Reynolds C.M., McGillicuddy F.C., Harford K.A., Finucane O.M., Mills K.H., Roche H.M. Dietary saturated fatty acids prime the NLRP3 inflammasome via TLR4 in dendritic cells-implications for diet-induced insulin resistance. Mol. Nutr. Food Res. 2012;6:1212–1222. doi: 10.1002/mnfr.201200058.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/mnfr.201200058</ArticleId>
            <ArticleId IdType="pubmed">22700321</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>O’Reilly M., Dillon E., Guo W., Finucane O., McMorrow A., Murphy A., Lyons C., Jones D., Ryan M., Gibney M., et al.  High-Density Lipoprotein Proteomic Composition, and not Efflux Capacity, Reflects Differential Modulation of Reverse Cholesterol Transport by Saturated and Monounsaturated Fat Diets. Circulation. 2016;133:1838–1850. doi: 10.1161/CIRCULATIONAHA.115.020278.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1161/CIRCULATIONAHA.115.020278</ArticleId>
            <ArticleId IdType="pmc">PMC6122580</ArticleId>
            <ArticleId IdType="pubmed">27081117</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rodríguez-Prados J.C., Través P.G., Cuenca J., Rico D., Aragonés J., Martín-Sanz P., Cascante M., Boscá L. Substrate fate in activated macrophages: A comparison between innate, classic, and alternative activation. J. Immunol. 2010;185:605–614. doi: 10.4049/jimmunol.0901698.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.4049/jimmunol.0901698</ArticleId>
            <ArticleId IdType="pubmed">20498354</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jha A.K., Huang S.C., Sergushichev A., Lampropoulou V., Ivanova Y., Loginicheva E., Chmielewski K., Stewart K.M., Ashall J., Everts B., et al.  Network Integration of Parallel Metabolic and Transcriptional Data Reveals Metabolic Modules that Regulate Macrophage Polarization. Immunity. 2015;42:419–430. doi: 10.1016/j.immuni.2015.02.005.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.immuni.2015.02.005</ArticleId>
            <ArticleId IdType="pubmed">25786174</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Vats D., Mukundan L., Odegaard J.I., Zhang L., Smith K.L., Morel C.R., Wagner R.A., Greaves D.R., Murray P.J., Chawla A. Oxidative metabolism and PGC-1beta attenuate macrophage-mediated inflammation. Cell Metab. 2006;4:13–24. doi: 10.1016/j.cmet.2006.05.011.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.cmet.2006.05.011</ArticleId>
            <ArticleId IdType="pmc">PMC1904486</ArticleId>
            <ArticleId IdType="pubmed">16814729</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>MacIver N.J., Michalek R.D., Rathmell J.C. Metabolic regulation of T lymphocytes. Annu. Rev. Immunol. 2013;31:259–283. doi: 10.1146/annurev-immunol-032712-095956.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1146/annurev-immunol-032712-095956</ArticleId>
            <ArticleId IdType="pmc">PMC3606674</ArticleId>
            <ArticleId IdType="pubmed">23298210</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Michalek R.D., Gerriets V.A., Jacobs S.R., Macintyre A.N., MacIver N.J., Mason E.F., Sullivan S.A., Nichols A.G., Rathmell J.C. Cutting edge: Distinct glycolytic and lipid oxidative metabolic programs are essential for effector and regulatory CD4+ T cell subsets. J. Immunol. 2011;186:3299–3303. doi: 10.4049/jimmunol.1003613.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.4049/jimmunol.1003613</ArticleId>
            <ArticleId IdType="pmc">PMC3198034</ArticleId>
            <ArticleId IdType="pubmed">21317389</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Blagih J., Coulombe F., Vincent E.E., Dupuy F., Galicia-Vázquez G., Yurchenko E., Raissi T.C., van der Windt G.J., Viollet B., Pearce E.L., et al.  The Energy Sensor AMPK Regulates T Cell Metabolic Adaptation and Effector Responses In Vivo. Immunity. 2015;42:41–54. doi: 10.1016/j.immuni.2014.12.030.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.immuni.2014.12.030</ArticleId>
            <ArticleId IdType="pubmed">25607458</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>MacIver N.J., Blagih J., Saucillo D.C., Tonelli L., Griss T., Rathmell J.C., Jones R.G. The Liver Kinase B1 Is a Central Regulator of T Cell Development, Activation, and Metabolism. J. Immunol. 2011;187:4187–4198. doi: 10.4049/jimmunol.1100367.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.4049/jimmunol.1100367</ArticleId>
            <ArticleId IdType="pmc">PMC3206094</ArticleId>
            <ArticleId IdType="pubmed">21930968</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Rolf J., Zarrouk M., Finlay D.K., Foretz M., Viollet B., Cantrell D.A. AMPKα1: A glucose sensor that controls CD8 T-cell memory. Eur. J. Immunol. 2013;43:889–896. doi: 10.1002/eji.201243008.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/eji.201243008</ArticleId>
            <ArticleId IdType="pmc">PMC3734624</ArticleId>
            <ArticleId IdType="pubmed">23310952</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Poznanski S.M., Barra N.G., Ashkar A.A., Schertzer J.D. Immunometabolism of T cells and NK cells: Metabolic control of effector and regulatory function. Inflamm. Res. 2018;67:813–828. doi: 10.1007/s00011-018-1174-3.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00011-018-1174-3</ArticleId>
            <ArticleId IdType="pubmed">30066126</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Palsson-McDermott E.M., Curtis A.M., Goel G., Lauterbach M.A.R., Sheedy F.J., Gleeson L.E., van den Bosch M.W.M., Quinn S.R., Domingo-Fernandez R., Johnston D.G.W., et al.  Pyruvate kinase M2 regulates Hif-1α activity and IL-1β induction and is a critical determinant of the warburg effect in LPS-activated macrophages. Cell Metab. 2015;21:65–80. doi: 10.1016/j.cmet.2014.12.005.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.cmet.2014.12.005</ArticleId>
            <ArticleId IdType="pmc">PMC5198835</ArticleId>
            <ArticleId IdType="pubmed">25565206</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kirchner J., Brüne B., Namgaladze D. AICAR inhibits NFκB DNA binding independently of AMPK to attenuate LPS-triggered inflammatory responses in human macrophages. Sci. Rep. 2018;8:7081. doi: 10.1038/s41598-018-26102-3.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1038/s41598-018-26102-3</ArticleId>
            <ArticleId IdType="pmc">PMC5958102</ArticleId>
            <ArticleId IdType="pubmed">29773845</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Moon J.S., Nakahira K., Choi A.M. Fatty acid synthesis and NLRP3-inflammasome. Oncotarget. 2015;6:21765–21766. doi: 10.18632/oncotarget.4781.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.18632/oncotarget.4781</ArticleId>
            <ArticleId IdType="pmc">PMC4673109</ArticleId>
            <ArticleId IdType="pubmed">26314848</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Cacicedo J.M., Yagihashi N., Keaney J.F., Jr, Ruderman N.B., Ido Y. AMPK inhibits fatty acid-induced increases in NF-kappaB transactivation in cultured human umbilical vein endothelial cells. Biochem. Biophys. Res. Commun. 2004;324:1204–1209. doi: 10.1016/j.bbrc.2004.09.177.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.bbrc.2004.09.177</ArticleId>
            <ArticleId IdType="pubmed">15504342</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Dicter N., Madar Z., Tirosh O. α-Lipoic Acid Inhibits Glycogen Synthesis in Rat Soleus Muscle via Its Oxidative Activity and the Uncoupling of Mitochondria. J. Nutr. 2002;132:3001–3006. doi: 10.1093/jn/131.10.3001.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1093/jn/131.10.3001</ArticleId>
            <ArticleId IdType="pubmed">12368386</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Lee W.J., Song K.H., Koh E.H., Won J.C., Kim H.S., Park H.S., Kim M.S., Kim S.W., Lee K.U., Park J.Y. α-Lipoic acid increases insulin sensitivity by activating AMPK in skeletal muscle. Biochem. Biophys. Res. Commun. 2005;332:885–891. doi: 10.1016/j.bbrc.2005.05.035.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.bbrc.2005.05.035</ArticleId>
            <ArticleId IdType="pubmed">15913551</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Timmers S., de Vogel-van den Bosch J., Towler M.C., Schaart G., Moonen-Kornips E., Mensink R.P., Hesselink M.K., Hardie D.G., Schrauwen P. Prevention of high-fat diet-induced muscular lipid accumulation in rats by α lipoic acid is not mediated by AMPK activation. J. Lipid Res. 2010;51:352–359. doi: 10.1194/jlr.M000992.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1194/jlr.M000992</ArticleId>
            <ArticleId IdType="pmc">PMC2803237</ArticleId>
            <ArticleId IdType="pubmed">19690335</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Park K.G., Min A.K., Koh E.H., Kim H.S., Kim M.O., Park H.S., Kim Y.D., Yoon T.S., Jang B.K., Hwang J.S., et al.  Alpha-lipoic acid decreases hepatic lipogenesis through adenosine monophosphate-activated protein kinase (AMPK)-dependent and AMPK-independent pathways. Hepatology. 2008;48:1477–1486. doi: 10.1002/hep.22496.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/hep.22496</ArticleId>
            <ArticleId IdType="pubmed">18972440</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Yang Y., Li W., Liu Y., Sun Y., Li Y., Yao Q., Li J., Zhang Q., Gao Y., Gao L., et al.  Alpha-lipoic acid improves high-fat diet-induced hepatic steatosis by modulating the transcription factors SREBP-1, FoxO1 and Nrf2 via the SIRT1/LKB1/AMPK pathway. J. Nutr. Biochem. 2014;25:1207–1217. doi: 10.1016/j.jnutbio.2014.06.001.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jnutbio.2014.06.001</ArticleId>
            <ArticleId IdType="pubmed">25123628</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kratz M., Coats B.R., Hisert K.B., Hagman D., Mutskov V., Peris E., Schoenfelt K.Q., Kuzma J.N., Larson I., Billing P.S., et al.  Metabolic dysfunction drives a mechanistically distinct proinflammatory phenotype in adipose tissue macrophages. Cell Metab. 2014;20:614–625. doi: 10.1016/j.cmet.2014.08.010.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.cmet.2014.08.010</ArticleId>
            <ArticleId IdType="pmc">PMC4192131</ArticleId>
            <ArticleId IdType="pubmed">25242226</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chan K.L., Pillon N.J., Sivaloganathan D.M., Costford S.R., Liu Z., Théret M., Chazaud B., Klip A. Palmitoleate Reverses High Fat-induced Proinflammatory Macrophage Polarization via AMP-activated Protein Kinase (AMPK) J. Biol. Chem. 2015;290:16979–16988. doi: 10.1074/jbc.M115.646992.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1074/jbc.M115.646992</ArticleId>
            <ArticleId IdType="pmc">PMC4505442</ArticleId>
            <ArticleId IdType="pubmed">25987561</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Xiong X.Q., Geng Z., Zhou B., Zhang F., Han Y., Zhou Y.B., Wang J.J., Gao X.Y., Chen Q., Li Y.H., et al.  FNDC5 attenuates adipose tissue inflammation and insulin resistance via AMPK-mediated macrophage polarization in obesity. Metabolism. 2018;83:31–41. doi: 10.1016/j.metabol.2018.01.013.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.metabol.2018.01.013</ArticleId>
            <ArticleId IdType="pubmed">29374559</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Van Dijk S.J., Feskens E.J., Bos M.B., Hoelen D.W., Heijligenberg R., Bromhaar M.G., de Groot L.C., de Vries J.H., Müller M., Afman L.A. A saturated fatty acid—Rich diet induces an obesity-linked proinflammatory gene expression profile in adipose tissue of subjects at risk of metabolic syndrome. Am. J. Clin. Nutr. 2009;90:1656–1664. doi: 10.3945/ajcn.2009.27792.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3945/ajcn.2009.27792</ArticleId>
            <ArticleId IdType="pubmed">19828712</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chen S., Zhao Z., Ke L., Li Z., Li W., Zhang Z., Zhou Y., Feng X., Zhu W. Resveratrol improves glucose uptake in insulin-resistant adipocytes via Sirt1. J. Nutr. Biochem. 2018;55:209–218. doi: 10.1016/j.jnutbio.2018.02.007.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jnutbio.2018.02.007</ArticleId>
            <ArticleId IdType="pubmed">29554499</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Hwang J.T., Kwak D.W., Lin S.K., Kim H.M., Kim Y.M., Park O.J. Resveratrol Induces Apoptosis in Chemoresistant Cancer Cells via Modulation of AMPK Signaling Pathway. Ann. N. Y. Acad. Sci. 2007;1095:441–448. doi: 10.1196/annals.1397.047.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1196/annals.1397.047</ArticleId>
            <ArticleId IdType="pubmed">17404056</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kim W.S., Lee Y.S., Cha S.H., Jeong H.W., Choe S.S., Lee M.R., Oh G.T., Park H.S., Lee K.U., Lane M.D., et al.  Berberine improves lipid dysregulation in obesity by controlling central and peripheral AMPK activity. Am. J. Physiol. Endocrinol. Metab. 2009;296:812–819. doi: 10.1152/ajpendo.90710.2008.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1152/ajpendo.90710.2008</ArticleId>
            <ArticleId IdType="pubmed">19176354</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Turner N., Li J.Y., Gosby A., To S.W., Cheng Z., Miyoshi H., Taketo M.M., Cooney G.J., Kraegen E.W., James D.E., et al.  Berberine and its more biologically available derivative, dihydroberberine, inhibit mitochondrial respiratory complex I: A mechanism for the action of berberine to activate AMP-activated protein kinase and improve insulin action. Diabetes. 2008;57:1414–1418. doi: 10.2337/db07-1552.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.2337/db07-1552</ArticleId>
            <ArticleId IdType="pubmed">18285556</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Kim H.S., Kim M.J., Kim E.J., Yang Y., Lee M.S., Lim J.S. Berberine-induced AMPK activation inhibits the metastatic potential of melanoma cells via reduction of ERK activity and COX-2 protein expression. Biochem. Pharmacol. 2011;83:385–394. doi: 10.1016/j.bcp.2011.11.008.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.bcp.2011.11.008</ArticleId>
            <ArticleId IdType="pubmed">22120676</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Shehzad A., Ha T., Subhan F., Lee Y.S. New mechanisms and the anti-inflammatory role of curcumin in obesity and obesity-related metabolic diseases. Eur. J. Nutr. 2011;50:151–161. doi: 10.1007/s00394-011-0188-1.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1007/s00394-011-0188-1</ArticleId>
            <ArticleId IdType="pubmed">21442412</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Um M.Y., Hwang K.H., Ahn J., Ha T.Y. Curcumin Attenuates Diet-Induced Hepatic Steatosis by Activating AMP-Activated Protein Kinase. Basic Clin. Pharmacol. Toxicol. 2013;113:152–157. doi: 10.1111/bcpt.12076.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1111/bcpt.12076</ArticleId>
            <ArticleId IdType="pubmed">23574662</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Na L.X., Zhang Y.L., Li Y., Liu L.Y., Li R., Kong T., Sun C.H. Curcumin improves insulin resistance in skeletal muscle of rats. Nutr. Metab. Cardiovasc. Dis. 2011;21:526–533. doi: 10.1016/j.numecd.2009.11.009.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.numecd.2009.11.009</ArticleId>
            <ArticleId IdType="pubmed">20227862</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Pan W., Yang H., Cao C., Song X., Wallin B., Kivlin R., Lu S., Hu G., Di W., Wan Y. AMPK mediates curcumin-induced cell death in CaOV3 ovarian cancer cells. Oncol. Rep. 1994;20:1553–1559.</Citation>
          <ArticleIdList>
            <ArticleId IdType="pubmed">19020741</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Panche A.N., Diwan A.D., Chandra S.R. Flavonoids: An overview. J. Nutr. Sci. 2016;5:e47. doi: 10.1017/jns.2016.41.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1017/jns.2016.41</ArticleId>
            <ArticleId IdType="pmc">PMC5465813</ArticleId>
            <ArticleId IdType="pubmed">28620474</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ha B.G., Nagaoka M., Yonezawa T., Tanabe R., Woo J.T., Kato H., Chung U.I., Yagasaki K. Regulatory mechanism for the stimulatory action of genistein on glucose uptake in vitro and in vivo. J. Nutr. Biochem. 2012;23:501–519. doi: 10.1016/j.jnutbio.2011.02.007.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.jnutbio.2011.02.007</ArticleId>
            <ArticleId IdType="pubmed">21684132</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ji G., Zhang Y., Yang Q., Cheng S., Hao J., Zhao X., Jiang Z. Genistein Suppresses LPS-Induced Inflammatory Response through Inhibiting NF-κB following AMP Kinase Activation in RAW 264.7 Macrophages. PLoS ONE. 2012;7:e53101.  doi: 10.1371/journal.pone.0053101.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1371/journal.pone.0053101</ArticleId>
            <ArticleId IdType="pmc">PMC3534028</ArticleId>
            <ArticleId IdType="pubmed">23300870</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Palacios-González B., Zarain-Herzberg A., Flores-Galicia I., Noriega L.G., Alemán-Escondrillas G., Zariñan T., Ulloa-Aguirre A., Torres N., Tovar A.R. Genistein stimulates fatty acid oxidation in a leptin receptor-independent manner through the JAK2-mediated phosphorylation and activation of AMPK in skeletal muscle. Biochim. Biophys. Acta Mol. Cell Biol. Lipids. 2014;1841:132–140. doi: 10.1016/j.bbalip.2013.08.018.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.bbalip.2013.08.018</ArticleId>
            <ArticleId IdType="pubmed">24013029</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Ono M., Fujimori K. Antiadipogenic Effect of Dietary Apigenin through Activation of AMPK in 3T3-L1 Cells. J. Agric. Food Chem. 2011;59:13346–13352. doi: 10.1021/jf203490a.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1021/jf203490a</ArticleId>
            <ArticleId IdType="pubmed">22098587</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Choi W.H., Son H.J., Jang Y.J., Ahn J., Jung C.H., Ha T.Y. Apigenin Ameliorates the Obesity-Induced Skeletal Muscle Atrophy by Attenuating Mitochondrial Dysfunction in the Muscle of Obese Mice. Mol. Nutr. Food Res. 2017;61:1700218. doi: 10.1002/mnfr.201700218.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1002/mnfr.201700218</ArticleId>
            <ArticleId IdType="pubmed">28971573</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Jung U.J., Cho Y.Y., Choi M.S. Apigenin Ameliorates Dyslipidemia, Hepatic Steatosis and Insulin Resistance by Modulating Metabolic and Transcriptional Profiles in the Liver of High-Fat Diet-Induced Obese Mice. Nutrients. 2016;8:305.  doi: 10.3390/nu8050305.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.3390/nu8050305</ArticleId>
            <ArticleId IdType="pmc">PMC4882717</ArticleId>
            <ArticleId IdType="pubmed">27213439</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Sung B., Chung H.Y., Kim N.D. Role of Apigenin in Cancer Prevention via the Induction of Apoptosis and Autophagy. J. Cancer Prev. 2016;21:216–226. doi: 10.15430/JCP.2016.21.4.216.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.15430/JCP.2016.21.4.216</ArticleId>
            <ArticleId IdType="pmc">PMC5207605</ArticleId>
            <ArticleId IdType="pubmed">28053955</ArticleId>
          </ArticleIdList>
        </Reference>
        <Reference>
          <Citation>Chang H.C., Guarente L. SIRT1 and other sirtuins in metabolism. Trends Endocrinol. Metab. 2014;25:138–145. doi: 10.1016/j.tem.2013.12.001.</Citation>
          <ArticleIdList>
            <ArticleId IdType="doi">10.1016/j.tem.2013.12.001</ArticleId>
            <ArticleId IdType="pmc">PMC3943707</ArticleId>
            <ArticleId IdType="pubmed">24388149</ArticleId>
          </ArticleIdList>
        </Reference>
      </ReferenceList>
    </PubmedData>
  </PubmedArticle>
</PubmedArticleSet>
